GL1X · GenesisL1 explorer

Research workbench

Cereblon isoform 4 from magnetospirillum gryphiswaldense in complex with thalidomide, wash II structure

Analyse Cereblon isoform 4 from magnetospirillum gryphiswaldense in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AMJ
Type
protein
Length
281 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cereblon isoform 4
UniProt
A4TVL0
Ligands
EF2, ZN, PO4
Pockets
5 · best druggability 0.46

Structure

x-ray diffraction · 3 distinct chains · 9% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACereblon isoform 4protein1078% helix, 49% strandA4TVL0
BCereblon isoform 4protein1059% helix, 52% strandA4TVL0
CCereblon isoform 4protein699% helix, 49% strandA4TVL0

Ligands and binding sites

  • EF2 · S-Thalidomide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 3 copies · chains A, B, C
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11570.460.7623empty
2810.450.8121empty
31410.410.7419PO4
4550.410.8112EF2
5650.390.7913EF2

Interfaces

2 interfaces between chains.

  • A–B · 618 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 489 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5AMJ · Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with Thalidomide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.